|
1B9G
INSULIN-LIKE-GROWTH-FACTOR-1
提交 1999-02-11
|
构建体不同
突变/修饰不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
1–57(57 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
NMR测量条件
pH 1.9;293 K
|
分辨率未提供
|
|
1GZR
Human Insulin-like growth factor; ESRF data
提交 2002-05-28
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
49–118(70 aa)
|
未记录
|
C15 N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;THE PROTEIN WAS CRYSTALLIZED BY THE HANGING DROP METHOD IN WHICH DROPS WERE COMPOSED OF VARIOUS RATIOS OF HIGF-I AT 7MG/ML (IN H2O) WITH RESERVOIR SOLUTION CONSISTING OF 0.1M TRIS.HCL PH 7.5, 12-15% (W/V) PEG 2K AND 5MM SB12 DETERGENT.
|
分辨率 2.00 Å
R-free 0.295
|
|
1GZY
Human Insulin-like growth factor; In-house data
提交 2002-06-10
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
49–118(70 aa)
|
未记录
|
C15 N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;THE PROTEIN WAS CRYSTALLIZED BY THE HANGING DROP METHOD IN WHICH DROPS WERE COMPOSED OF VARIOUS RATIOS OF HIGF-I AT 7MG/ML (IN H2O) WITH RESERVOIR SOLUTION CONSISTING OF 0.1M TRIS.HCL PH 7.5, 12-15% (W/V) PEG 2K AND 5MM SB12 DETERGENT.
|
分辨率 2.54 Å
R-free 0.265
|
|
1GZZ
Human Insulin-like growth factor; Hamburg data
提交 2002-06-10
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
49–118(70 aa)
|
未记录
|
C15 N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;THE PROTEIN WAS CRYSTALLIZED BY THE HANGING DROP METHOD IN WHICH DROPS WERE COMPOSED OF VARIOUS RATIOS OF HIGF-I AT 7MG/ML (IN H2O) WITH RESERVOIR SOLUTION CONSISTING OF 0.1M TRIS.HCL PH 7.5, 12-15% (W/V) PEG 2K AND 5MM SB12 DETERGENT.
|
分辨率 2.30 Å
R-free 0.275
|
|
1H02
Human Insulin-like growth factor; SRS Daresbury data
提交 2002-06-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 B
49–118(70 aa)
|
未记录
|
C15 N-DODECYL-N,N-DIMETHYL-3-AMMONIO-1-PROPANESULFONATE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7.5;THE PROTEIN WAS CRYSTALLIZED BY THE HANGING DROP METHOD IN WHICH DROPS WERE COMPOSED OF VARIOUS RATIOS OF HIGF-I AT 7MG/ML (IN H2O) WITH RESERVOIR SOLUTION CONSISTING OF 0.1M TRIS.HCL PH 7.5, 12-15% (W/V) PEG 2K AND 5MM SB12 DETERGENT.
|
分辨率 2.00 Å
R-free 0.300
|
|
1H59
Complex of IGFBP-5 with IGF-I
提交 2001-05-21
|
构建体不同
突变/修饰不同
聚集状态不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 6
PDB 声明:hexameric
|
链 A
49–118(70 aa)
片段:RESIDUES 49-118
|
未记录
|
未记录非水小分子
|
X-RAY DIFFRACTION
X-ray结晶条件
pH 5.6;pH 5.60
|
分辨率 2.10 Å
R-free 0.262
|
|
1IMX
1.8 Angstrom crystal structure of IGF-1
提交 2001-05-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
49–118(70 aa)
|
未记录
|
BR BROMIDE ION × 1
CPQ N,N-BIS(3-D-GLUCONAMIDOPROPYL)DEOXYCHOLAMIDE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;PEG 3350, deoxy big CHAPS, sodium cacodylate, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
分辨率 1.82 Å
R-free 0.258
|
|
2GF1
SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE GROWTH FACTOR 1: A NUCLEAR MAGNETIC RESONANCE AND RESTRAINED MOLECULAR DYNAMICS STUDY
提交 1991-01-23
|
构建体不同
突变/修饰不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
49–118(70 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
mmCIF 未提供已读取条件
|
分辨率未提供
|
|
3GF1
SOLUTION STRUCTURE OF HUMAN INSULIN-LIKE GROWTH FACTOR 1: A NUCLEAR MAGNETIC RESONANCE AND RESTRAINED MOLECULAR DYNAMICS STUDY
提交 1991-01-24
|
构建体不同
突变/修饰不同
实验方法不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白单体
单体;蛋白 × 1
PDB 声明:monomeric
|
链 A
49–118(70 aa)
|
未记录
|
未记录非水小分子
|
SOLUTION NMR
mmCIF 未提供已读取条件
|
分辨率未提供
|